Charles Mather

Track

Insider profile

Currently holds a position at Hyperion DeFi Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 28% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Hyperion DeFi Inc March 26, 2018 -
Independent Director Tonix Pharmaceuticals Holding Corp Oct. 14, 2011 - Feb. 16, 2019
Charles Mather's trades of Hyperion DeFi Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
111.19
Quantity 16,430
Value US$4,993,361
Transaction date
Purchase
Price
332.62
Quantity 30,846 -15.2%
Value US$2,612,015
Transaction date
Purchase
Price
120.56
Quantity 48,481 -9.4%
Value US$3,536,880
Transaction date
Purchase
Price
3.83
Quantity 4,000 +15.2%
Value US$15,314
Transaction date
Purchase
Price
4.76
Quantity 3,000 +12.8%
Value US$14,268
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-07-22 2025-07-22
PrS Proposed sale
16,430
111.19
US$4,993,361 		16,430 111.19 US$4,993,361
2023-05-30 2023-05-26
B Purchase
30,846 -15.2%
332.62
US$2,612,015 		30,846 -15.2% 332.62 US$2,612,015
2022-05-19 2022-05-18
B Purchase
48,481 -9.4%
120.56
US$3,536,880 		48,481 -9.4% 120.56 US$3,536,880
2021-11-01 2021-11-01
B Purchase
4,000 +15.2%
3.83
US$15,314 		4,000 +15.2% 3.83 US$15,314
2021-05-28 2021-05-28
B Purchase
3,000 +12.8%
4.76
US$14,268 		3,000 +12.8% 4.76 US$14,268